ABOUT THE EXPERT
Co-Director, Urologic Oncology
Medical Director, TomoTherapy
John Theurer Cancer Center
Dr Gejerman, the co-chief of the Division of Urologic Oncology and Medical Director of TomoTherapy, has spearheaded the development of John Theurer Cancer Center’s Radiation Oncology Department, one of the largest programs of its kind in New Jersey. Dr Gejerman is also a member of Regional Cancer Center Associates, New Jersey’s largest oncology physician network. Dr Gejerman brings novel, emerging techniques and technologies to patients. His department offers patients access to every treatment option available, including brachytherapy, TrueBeam, and the TomoTherapy system. TomoTherapy delivers a very sophisticated form of intensity modulated radiation therapy (IMRT) using an integrated treatment system that is unlike any other – giving patients unparalleled accuracy, precision and safety. Dr Gejerman is dedicated to making radiation therapy safer for patients. He is one of the first radiation oncologists in the tristate area to begin implanting a wireless radiation sensor, which allows oncologists to receive data on the precise amount of radiation being delivered to tumors and surrounding tissue.
His research interests include all types of radiation therapy for prostate cancer, including IMRT, TomoTherapy, brachytherapy (radioactive seed implantation), and high-dose-rate brachytherapy (using catheters to deliver the radiation), as well as the use of IMRT and traditional external beam radiation therapy to treat other cancers. He completed his medical degree at UMDNJ-New Jersey Medical School, and his residency/fellowship in Radiation Oncology at Montefiore Medical Center, Weiler Hospital, and Albert Einstein College of Medicine. He is board certified in therapeutic radiology.